What is RAPP's dilution risk score?

RAPP has a latest available DilutionScore record of 34/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for RAPP, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for RAPP?

DilutionWatch tracks 25 SEC filing types for RAPP including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect RAPP shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For RAPP, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for RAPP tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for RAPP. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

RAPP Dilution Risk Score: 34/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

0

📊 Float Risk

25

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 9%

💰 Capital Raise model 18%

• Active ATM program with $110M remaining capacity

🔔 Track RAPP — Get forecast alerts →

Market Data

Market Cap$1.89B

Shares Outstanding47.98M

Float31.75M

Cash$436.08M

Debt$10.80M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 19.6% shares (2026Q1 vs prior)

148 institutional holders · 61.74M shares

#1 FMR LLC 7.17M shares

#2 TRV GP V, LLC 7.14M shares

#3 GOLDMAN SACHS GROUP INC 5.94M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.25M

Days to Cover7.5

% of Float7.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

4 INSIDER TRANSACTION 2026-03-31

4 INSIDER TRANSACTION 2026-03-26

4 INSIDER TRANSACTION 2026-03-09

4 INSIDER TRANSACTION 2026-02-19

4 INSIDER TRANSACTION 2026-02-04

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual RAPP Dilution Snapshot

Rapport Therapeutics, Inc. (RAPP) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $110.0M.
Recent SEC activity tracked for RAPP: 4 on 2026-03-31; 4 on 2026-03-26; 4 on 2026-03-09.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.